Cytomegalovirus (CMV) Retinitis Global Clinical Trials

1. Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014 (Type, Mode of action, Crop Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com Published on : Oct 2014

2. Report Overview Research Beam adds a report titled “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014” that provides latest market trends and opportunities. The report offers detailed analysis of the Cytomegalovirus (CMV) Retinitis. Summary GlobalData's clinical trial report, “Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cytomegalovirus (CMV) Retinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated)

3. Report Overview Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Complete report is available at: http://www.researchbeam.com/cytomegalovirus-cmv-retinitis-global-clinical-trials-review-h2-2014-market

4. Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Introduction 5 Cytomegalovirus (CMV) Retinitis 5 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Countries Contributing to Clinical Trials in Europe 8 Top Countries Contributing to Clinical Trials in North America 9 Clinical Trials by G7 Countries: Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials 10 Clinical Trials by Phase in G7 Countries 11 Clinical Trials in G7 Countries by Trial Status 12 Clinical Trials by Phase 13 Clinical Trials by Trial Status 14 Clinical Trials by End Point Status 15 Unaccomplished Trials of Cytomegalovirus (CMV) Retinitis 16 Clinical Trials by Sponsor Type 17 Prominent Sponsors 18 Top Companies Participating in Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials 19 Prominent Drugs 20 Clinical Trial Profiles 21

5. Similar Market Studies • Published Reports • Enquire Before Buying: • http://www.researchbeam.com/cytomegalovirus-cmv-retinitis-global-clinical-trials-review-h2-2014-market/enquire-about-report • Similar market studies : • Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018 • Osteoporosis Drugs Markets in China • Mental Illness Drugs Markets in China

6. FOR MORE DETAILS Visit us at : www.researchbeam.com/cytomegalovirus-cmv-retinitis-global-clinical-trials-review-h2-2014-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com